Search Results 31-40 of 15987 for Purine

  1. Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations - Mayo Clinic

    Cytotoxic anticancer therapy (e.g., alkylating agents, anti-metabolites, purine analogues) or any other systemic anticancer therapy within 2 weeks of study ...

  2. Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    Use of calcineurin inhibitors or purine analogues, or potent cytochrome P450 (CYP) 3A4 inhibitors in the 12 weeks prior to Screening;; Have a ...

  3. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  4. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  5. Glomerulonephritis (inflammation in the kidney cells that filter waste from the blood); High blood pressure (hypertension) · IgA nephropathy (Berger disease) ( ...

  6. Consumer health basics

    Take charge of your health. Know your options. Use medicines and supplements wisely. Be informed and ask questions of your health care professionals.

  7. Drugs and Supplements that Start with G - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...

  8. Master Menu Ingredients Report - Mayo Clinic

    Breakfast Entrées. Texas Toast French Toast egg, liquid, substitute, cholesterol free, pasteurized, fresh | flavoring, extract, vanilla, imitation * |.

  9. Texture Modified Menu Ingredient Report - Mayo Clinic

    egg, liquid, substitute, cholesterol free, pasteurized, fresh | spice, cinnamon, ground * | milk, skim * | flavoring, extract, vanilla, imitation * | bread, ...

  10. A Study to Evaluate the Safety and Effectiveness of APT-1011 to Treat Eosinophilic Esophagitis - Mayo Clinic

    Use of calcineurin inhibitors or purine analogues (azathioprine, 6-mercaptopurine) in the 12 weeks before Screening. Use of potent cytochrome P450 (CYP) 3A4 ...